Cardioxyl Pharmaceuticals has named Dr. James Gilbert chief medical officer, a newly created position, as the Chapel Hill, N.C.-based company drives a new drug for acute decompensated heart failure through the clinical trial process.
Cardioxyl appoints first CMO
Gilbert, 57, most recently worked as CMO at Archemix Corp., where he helped guide a drug through the similar clinical trials for that company, according to a Cardioxyl news release.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.